Biosplice Therapeutics
ID: 7640899Small Molecules Acting on Stem Cells. Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
6
Funding Rounds
$799.0m
Money raised
Recent Funding Rounds
Overview
Small Molecules Acting on Stem Cells. Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Biosplice Therapeutics has raised a total of $799m in funding over 6 rounds.
Key Insights:
- Biosplice Therapeutics Venture round, April 15, 2021: $120m
- Biosplice Therapeutics Series B round, August 6, 2018: $438m
- Biosplice Therapeutics Series D round, January 1, 2018: $21m
- Biosplice Therapeutics Series A round, September 1, 2013: $220m
Industries
Biosplice Therapeutics is active in the following industries: